Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

National Healthcare (NHC) Cost of Revenue (2016 - 2025)

National Healthcare (NHC) has disclosed Cost of Revenue for 16 consecutive years, with $96.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cost of Revenue rose 15.49% year-over-year to $96.2 million, compared with a TTM value of $377.2 million through Dec 2025, up 17.37%, and an annual FY2025 reading of $377.2 million, up 17.37% over the prior year.
  • Cost of Revenue was $96.2 million for Q4 2025 at National Healthcare, roughly flat from $96.6 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $96.6 million in Q3 2025 and bottomed at $62.5 million in Q4 2021.
  • Average Cost of Revenue over 5 years is $77.1 million, with a median of $73.2 million recorded in 2021.
  • The sharpest move saw Cost of Revenue decreased 8.3% in 2021, then increased 19.41% in 2025.
  • Year by year, Cost of Revenue stood at $62.5 million in 2021, then increased by 13.68% to $71.1 million in 2022, then decreased by 0.17% to $71.0 million in 2023, then increased by 17.37% to $83.3 million in 2024, then rose by 15.49% to $96.2 million in 2025.
  • Business Quant data shows Cost of Revenue for NHC at $96.2 million in Q4 2025, $96.6 million in Q3 2025, and $91.9 million in Q2 2025.